Compare Maravai LifeSciences Holdings Inc. Class A Common Stock (MRVI) vs AT&T Inc. (T) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Maravai LifeSciences Holdings Inc. Class A Common Stock vs AT&T Inc. — how do they compare? Maravai LifeSciences Holdings Inc. Class A Common Stock trades at $6.56 (market cap $972.90M), while AT&T Inc. trades at $23.27 (market cap $156.58B). The key difference: AT&T Inc. is far larger — about 160.9× Maravai LifeSciences Holdings Inc. Class A Common Stock's market cap, and AT&T Inc. pays a 4.86% dividend while Maravai LifeSciences Holdings Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Maravai LifeSciences Holdings Inc. Class A Common Stock for 0 Days and AT&T Inc. for 118 Days on average.
| MRVI | T | |
|---|---|---|
Market Cap | $972.90M | $156.58B |
Volume | 4,325,710 | 46,597,672 |
Sector | Health | Media |
52-Week High | $9.00 | $29.10 |
52-Week Low | $2.83 | $20.49 |
Typical Hold Time | 0 Days | 118 Days |
Enterprise Value | $1.08B | $301.90B |
Dividend Yield | — | 4.86% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Maravai LifeSciences (MRVI) trades at $6.53, down 7.51% in the last session amid mixed signals. The stock shows improving fundamentals with Q2 2026 revenue growth of 9% and three consecutive earnings beats, though it remains unprofitable with a -37.07% net margin. Technical analysis indicates neutral positioning with key support at $6 and resistance at $7. Recent news highlights patent expansions in China and institutional accumulation.
The outlook remains cautiously optimistic with analyst consensus pointing to 7% upside potential to the $7.00 price target. Key opportunities include margin expansion and RNA technology leadership, while risks center on persistent cash burn and competitive pressures in life sciences. The stock offers speculative growth potential for risk-tolerant investors.
AT&T (T) trades at $23.08, up 2.62% today, with strong fundamentals including a P/E of 7.54 and net income margin of 16.94%. Recent earnings beat expectations, with Q2 2026 EPS of $0.65 versus $0.59 expected. Technical indicators show a bearish overall signal despite bullish oscillators. The company maintains robust cash flow with $15.12B net cash flow in 2025 and recently announced a $3B fiber deal with Corning to support AI infrastructure growth.
Outlook remains mixed with analyst consensus price target of $27.39 offering 19% upside potential, though technical weakness and competitive pressures pose risks. The stock's 4% dividend yield provides income support, but debt levels and legacy revenue declines require monitoring. Fiber expansion and wireless growth present opportunities amid challenging market conditions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Maravai LifeSciences Holdings Inc. Class A Common Stock
Maravai LifeSciences Holdings Inc. is a life sciences company supporting drug therapy, diagnostic, and vaccine development through four operating brands: TriLink BioTechnologies (nucleic acid and mRNA synthesis), Cygnus Technologies (biologics safety testing), Glen Research (oligonucleotide synthesis materials), and Alphazyme (enzyme manufacturing). It serves biotech and biopharma customers from discovery through commercial manufacturing.
Read more on MRVI →About AT&T Inc.
AT&T Inc. is a communications holding company. The Company, through its subsidiaries and affiliates, provides local and long-distance phone service, wireless and data communications, Internet access and messaging, IP-based and satellite television, security services, telecommunications equipment, and directory advertising and publishing.
Read more on T →
